- Lobeglitazone, A Peroxisome Proliferator-Activated Receptor-Gamma Agonist, Inhibits Papillary Thyroid Cancer Cell Migration and Invasion by Suppressing p38 MAPK Signaling Pathway
-
Jin JQ, Han JS, Ha J, Baek HS, Lim DJ
- KMID: 2521957
- Endocrinol Metab.
- 2021 Oct;36(5):1095-1110.
- doi: 10.3803/EnM.2021.1155
Background: Peroxisome proliferator-activated receptor-gamma (PPAR-γ) ligands have been widely shown to correlate with epithelial-mesenchymal transition (EMT) and cancer progression. Lobeglitazone (LGZ) is a novel ligand of PPAR-γ; and its role... -
- CITED
-
- Close
- SHARE
-
- Close
